Company: BNRG
Filing Date: 2025-04-09
Form Type: DRS
Source: 0001213900-25-030015
Chunk: 56

Company: Brenmiller Energy Ltd.
Filing Date: 2025-04-09
Form: DRS
Chunk 56
---
 this offering.

Listing

Our Ordinary Shares are listed
on the Nasdaq Capital Market under the symbol “BNRG.” There is no established public trading market for the Warrants or the Pre-Funded Warrants, and we do not expect a market to develop. We
do not plan on making an application to list the Warrants or the Pre-Funded Warrants on Nasdaq, any securities exchange or any recognized
trading system.

Discretionary Accounts

The placement agent does not
intend to confirm sales of the Ordinary Shares offered hereby to any accounts over which they have discretionary authority.

Other Activities and Relationships

The placement agent and
certain of its affiliates are full service financial institutions engaged in various activities, which may include securities
trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment,
hedging, financing and brokerage activities. The placement agent and certain of its affiliates have, from time to time, performed,
and may in the future perform, various commercial and investment banking and financial advisory services for us and our affiliates,
for which they received or will receive customary fees and expenses. On June 9, 2023, we entered into a Sales Agreement with
A.G.P./Alliance Global Partners, or the Sales Agent, pursuant to which we may offer and sell Ordinary Shares, from time to time, to
or through the Sales Agent as agent or principal Ordinary Shares in an “at the market offering”, as defined in Rule
415(a)(4) promulgated under the Securities Act, for an aggregate offering price of up to $9.35 million. We have agreed to pay the
Sales Agent a commission equal to 3.0% of the gross sales price per share sold pursuant to the terms of the Sales Agreement. We are
not obligated to sell any Ordinary Shares under the Sales Agreement and no assurance can be given as to the price or number of such
shares that we will sell or the dates on which any such sales will take place. As of April 8, 2025, we have sold 4,225,860 Ordinary
Shares under the Sales Agreement for aggregate gross proceeds of $8.1 million.

In addition, on January 22, 2024, we entered into a securities purchase agreement with a U.S.-based institutional investor, or the January
2024 Offering, for the issuance and sale of 240,000 Ordinary Shares, warrants to purchase up to 888,890 Ordinary Shares, or the January